Peer review reports
From: A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)
Original Submission |
5 Mar 2018 |
Submitted |
Original manuscript
|
9 May 2018 |
Author responded |
Author comments - Johannes Betge
|
Resubmission - Version 2 |
9 May 2018 |
Submitted |
Manuscript version 2
|
Publishing |
10 Jul 2018 |
Editorially accepted |
|
18 Jul 2018 |
Article published |
10.1186/s12885-018-4665-2
|
Learn about peer review